• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Research team recognized for organ-on-a-chip design

SCD is a group of genetic disorders that cause red blood cells to become misshapen and break down. From an early age, patients with sickle cell disease have a high risk of vascular disease and even stroke. Current models to test drugs used to treat SCD are not reliable and cannot accurately predict how a person’s body will respond to the medication. It is also difficult to predict which patients with the disease have the highest risk of suffering a stroke versus those who have the lowest.

The team is designing an organ-on-a-chip, consisting of a device that will mimic an artery of a pediatric sickle cell disease patient, and the associated biological readouts will provide information on the progression of vaso-occlusion, including during drug treatment.



To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.